首页> 美国卫生研究院文献>PLoS Clinical Trials >A Lower Degree of PBMC L1 Methylation in Women with Lower Folate Status May Explain the MTHFR C677T Polymorphism Associated Higher Risk of CIN in the US Post Folic Acid Fortification Era
【2h】

A Lower Degree of PBMC L1 Methylation in Women with Lower Folate Status May Explain the MTHFR C677T Polymorphism Associated Higher Risk of CIN in the US Post Folic Acid Fortification Era

机译:叶酸水平较低的女性中较低水平的PBMC L1甲基化程度可能解释了MTHFR C677T多态性与美国叶酸强化时代后CIN的较高风险有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundStudies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate as a result of the FA fortification program has altered the association between MTHFR C677T and risk of CIN, or the mechanisms involved with such alterations. The current study investigated the following in a FA fortified population: 1) The association between MTHFR C677T polymorphism and risk of CIN 2+; 2) The modifying effects of plasma folate concentrations on this association; and 3) The modifying effects of plasma folate on the association between the polymorphism and degree of methylation of long interspersed nucleotide elements (L1s), in peripheral blood mononuclear cell (PBMC) DNA, a documented biomarker of CIN risk.
机译:背景未进行叶酸(FA)强化的人群的研究表明,MTHFR C677T多态性与宫颈上皮内瘤样病变(CIN 2+)等级升高的风险增加相关。但是,尚不知道由于FA强化计划而接触较高的叶酸会改变MTHFR C677T与CIN风险之间的联系,还是改变这种改变的机制。当前的研究对FA强化人群进行了以下研究:1)MTHFR C677T多态性与CIN 2+风险之间的关联; 2)血浆叶酸浓度对此关联的修饰作用; 3)血浆叶酸对外周血单核细胞(PBMC)DNA中长散点核苷酸元件(L1s)的多态性与甲基化程度之间的关联的修饰作用,这是CIN风险的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号